Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery disease-Reference-Cited by-同舟云学术

Oral glycoprotein IIb/IIIa antagonism in patients with coronary artery disease

Published:2001-08 Issue:3 Volume:88 Page:236-242
ISSN:0002-9149
Container-title:The American Journal of Cardiology
language:en
Short-container-title:The American Journal of Cardiology

Author:

Catella-Lawson Francesca,Kapoor Shiv,Moretti Deborah,De Marco Susan,Vigilante Gary J.,Cucchiara Andrew J.,Ramsey Karen E.,Combe Sophie,Rocca Bianca,Theroux Pierre,FitzGerald Garret A.

Publisher

Elsevier BV

Subject

Cardiology and Cardiovascular Medicine

Reference29 articles.

1. Use of a monoclonal antibody directed against the platelet glycoprotein IIb/IIIa receptor in high-risk coronary angioplasty;N Engl J Med,1994

2. Effect of the platelet glycoprotein II/IIIa receptor inhibitor abciximab with lower heparin dosages on ischemic complications of percutaneous coronary revascularization;N Engl J Med,1997

3. Randomized placebo-controlled trial of abciximab before and during intervention in refractory unstable angina;Lancet,1997

4. Randomized controlled trial to assess safety of coronary stenting with use of abciximab;Lancet,1998

5. A comparison of aspirin plus tirofiban with aspirin plus heparin for unstable angina;N Engl J Med,1998

Cited by 5 articles. 订阅此论文施引文献订阅此论文施引文献，注册后可以免费订阅5篇论文的施引文献，订阅后可以查看论文全部施引文献

1. A new, vasoactive hybrid aspirin containing nitrogen monoxide-releasing molsidomine moiety;European Journal of Pharmaceutical Sciences;2019-04

2. Novel Anti-Platelets in Stable Coronary Artery Disease;Current Pharmaceutical Design;2016-09-02

3. Integrin αIIbβ3;Circulation Research;2013-04-12

4. Advances in ischemic stroke treatment: neuroprotective and combination therapies;Expert Opinion on Emerging Drugs;2007-03

5. Platelet hyperactivity in clinical depression and the beneficial effect of antidepressant drug treatment: how strong is the evidence?;Acta Psychiatrica Scandinavica;2004-09